Filed 3.0y ago· Jun 11, 2023
37 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
Eli Lilly
LLY
$1K-$15K
+138.9% vs S&P 500
Trade dateMay 5, 2023
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jun 11, 2023 3.0y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 5, 2023 37 days to disclose | Good buy·+$12K+150.0% +138.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 26, 2023 3.0y ago | ![]() Dan Newhouse RHouseWashington-04 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 26, 2023 30 days to disclose | Good buy·+$12K+149.7% +136.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 26, 2023 3.0y ago | ![]() Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Aug 5, 2022 294 days to disclose · 249 past 45-day window | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Mar 16, 2023 35 days to disclose | Flat·+0.0% +16.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Eli Lilly LLY | Mar 6, 2023 42 days to disclose | Good buy·+$18.5K+230.9% +215.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2023 3.2y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Csl Ltd. CSLLY Csl Ltd SPONSORED ADR | Feb 27, 2023 21 days to disclose | Bad buy·−$18.3K-56.3% −145.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 20, 2023 3.2y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Eli Lilly LLY | Feb 3, 2023 45 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 28, 2023 17 days to disclose | Flat·+0.0% +16.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 17, 2023 28 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 7, 2023 38 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 3, 2023 42 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Ally Financial ALLY | Jan 31, 2023 24 days to disclose | Flat·+0.0% +41.8% vs S&P 500 | $15K-$30K midpoint $22.5K |
Feb 24, 2023 3.3y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Eli Lilly LLY | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 17, 2023 3.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Jan 31, 2023 17 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 17, 2023 3.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Jan 11, 2023 37 days to disclose | Good buy·+$15.7K+196.8% +187.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2023 3.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Dec 1, 2022 43 days to disclose | Good buy·+$15.1K+188.8% +182.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 29, 2022 3.4y ago | ![]() Susie Lee DHouseNevada-03 | ↓sold | Ally Financial ALLY | Nov 30, 2022 29 days to disclose | Flat·+0.0% +75.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 26, 2022 3.4y ago | ![]() Nicholas V. Taylor —HouseTexas-03 | ↓sold | Eli Lilly LLY | Nov 28, 2022 28 days to disclose | Flat·+0.0% +9.1% vs S&P 500 | $1M-$5M midpoint $3M |
Nov 10, 2022 3.6y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Oct 20, 2022 21 days to disclose | Flat·+0.0% +20.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2022 3.8y ago | ![]() Susie Lee DHouseNevada-03 | ↓sold | Ally Financial ALLY 2000081228 JT Ally Financial | May 27, 2021 443 days to disclose · 398 past 45-day window | Flat·+0.0% +70.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Eli Lilly LLY | Jul 27, 2022 14 days to disclose | Good buy·+$17.7K+220.9% +208.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↓sold | Ally Financial ALLY | Jul 27, 2022 14 days to disclose | Flat·+0.0% +57.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 16, 2022 4.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Apr 28, 2022 18 days to disclose | Good buy·+$20.8K+259.8% +248.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2022 4.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Mar 16, 2022 32 days to disclose | Good buy·+$23K+286.9% +276.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2022 4.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Mar 15, 2022 33 days to disclose | Flat·+0.0% +12.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 14, 2022 31 days to disclose | Missed gain·−$85.2K-262.1% −208.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 7, 2021 4.7y ago | ![]() Zoe Lofgren DHouseCalifornia-18 | ↑bought | Ally Financial ALLY | Sep 30, 2021 7 days to disclose | Bad buy·−$1.5K-18.5% −56.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | May 5, 2021 141 days to disclose · 96 past 45-day window | Flat·+0.0% +71.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | Nov 18, 2019 675 days to disclose · 630 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | Nov 12, 2019 681 days to disclose · 636 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | ![]() Thomas R. Suozzi DHouseNew York-03 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Ways and Means | Aug 17, 2017 1498 days to disclose · 1453 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 10, 2021 4.7y ago | ![]() Zoe Lofgren DHouseCalifornia-18 | ↑bought | Ally Financial ALLY | Aug 9, 2021 32 days to disclose | Bad buy·−$1.6K-19.6% −56.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Eli Lilly LLY | Apr 16, 2020 381 days to disclose · 336 past 45-day window | price pending | $1K-$15K midpoint $8K |